Icecure Medical Ltd ICCM:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 04/29/24 EDT
1.20UNCH (UNCH)
Volume
65,702
52 week range
0.52 - 1.57
Loading...
  • Open1.20
  • Day High1.21
  • Day Low1.17
  • Prev Close1.20
  • 52 Week High1.57
  • 52 Week High Date01/30/24
  • 52 Week Low0.52
  • 52 Week Low Date09/20/23

Key Stats

  • Market Cap54.876M
  • Shares Out45.73M
  • 10 Day Average Volume1.52M
  • Dividend-
  • Dividend Yield-
  • Beta2.86
  • YTD % Change12.15

KEY STATS

  • Open1.20
  • Day High1.21
  • Day Low1.17
  • Prev Close1.20
  • 52 Week High1.57
  • 52 Week High Date01/30/24
  • 52 Week Low0.52
  • 52 Week Low Date09/20/23
  • Market Cap54.876M
  • Shares Out45.73M
  • 10 Day Average Volume1.52M
  • Dividend-
  • Dividend Yield-
  • Beta2.86
  • YTD % Change12.15

RATIOS/PROFITABILITY

  • EPS (TTM)-0.32
  • P/E (TTM)-3.74
  • Fwd P/E (NTM)-4.14
  • EBITDA (TTM)-15.253M
  • ROE (TTM)-77.97%
  • Revenue (TTM)3.229M
  • Gross Margin (TTM)40.26%
  • Net Margin (TTM)-453.76%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/20/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Icecure Medical Ltd

 

Profile

MORE
Icecure Medical Ltd is an Israel-based company that is engaged in the healthcare sector. The Company operates as commercial stage medical device company focusing on the research, development and marketing of cryoablation systems, disposables and technologies based on liquid nitrogen, or LN2, for treating tumors. Cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in breast, lungs, kidneys, bones and other...
Ron Mayron
Chairman of the Board
Eyal Shamir
Chief Executive Officer, Director
Elisabeth Sadka
Vice President-Clinics, Regulations and Quality Assurance
Ronen Tsimerman
Vice President - Finance, Vice President - Operations
Address
7 Ha'eshel St.,
PO Box 3163
Caesarea
3079504
Israel